Clinical efficacy of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal patients with cholestasis
Lists
Only you see this
Abstract
Phenobarbital combined with ursodeoxycholic acid can improve the liver function of children to a greater extent in the treatment of neonatal cholestasis. It can also reduce serum bilirubin concentration, has good clinical efficacy, does not cause serious adverse reactions, and has good safety.
BibTeX
@inproceedings{lin2025clinical,
author = {Jiang Lin and Qiuyu Jiang and Can Yang},
title = {{Clinical efficacy of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal patients with cholestasis}},
booktitle = {Arab},
year = {2025},
doi = {10.1016/j.ajg.2024.12.005},
}Loading related content...